medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 1

<< Back Next >>

Rev Mex Pediatr 2020; 87 (1)

Facial-cervical lymphangioma, prenatal detection

Salas-Samaniego MA, Cázarez-Ortiz M, Ramírez-Moreno MA
Full text How to cite this article 10.35366/93265

DOI

DOI: 10.35366/93265
URL: https://dx.doi.org/10.35366/93265

Language: Spanish
References: 11
Page: 26-29
PDF size: 241.06 Kb.


Key words:

Lymphangioma, OK-432, sclerosis, prenatal diagnosis, newborn.

ABSTRACT

Objective: To describe the case of a newborn with cervical-facial lymphangioma detected during pregnancy and who received treatment with OK-432 shortly after birth. Case presentation: Newborn with detection of cervical anatomic defect by ultrasound at 26 weeks of gestation; lymphangioma was suspected using other studies such as magnetic resonance imaging. The pregnancy came to term, which was stirred by cesarean section without complications. At birth and after performing other studies, the diagnosis of micro and macrocystic cervical-facial lymphangioma was confirmed. At eight days of age sclerotherapy with OK-432 was applied. After five and 10 weeks of treatment the lesion was significantly reduced. The patient evolved satisfactorily, without complications. Conclusions: Since lymphangiomas can be detected in the fetal period, in the early neonatal stage patients can receive treatment with OK-432.


REFERENCES

  1. Waner M, O TM. Multidisciplinary approach to the management of lymphatic malformations of the head and neck. Otolaryngol Clin North Am. 2018; 51(1): 159-172.

  2. Teissier N. Linfangiomas cervicofaciales: pruebas de imagen, diagnóstico y tratamiento. EMC Otorrinolaringología. 2017; 46: 1-15.

  3. Valle-Rodríguez, E, Villanueva-San Vicente, V, Rodríguez-González MA et al. Linfangioma cervical: manejo terapéutico con OK-432 (picibanil). Rev Esp Cir Oral y Maxilofac. 2007; 29: 399-403.

  4. Tongsong T, Luewan S, Khorana J, Sirilert S, Charoenratana C. Natural course of fetal axillary lymphangioma based on prenatal ultrasound studies. J Ultrasound Med. 2018; 37(5): 1273-1281.

  5. Bansal AG, Oudsema R, Masseaux JA, Rosenberg HK. US of pediatric superficial masses of the head and neck. Radiographics. 2018; 38(4): 1239-1263.

  6. Perkins JA. New frontiers in our understanding of lymphatic malformations of the head and neck (Natural History, basic research). Otolaryngol Clin North Am. 2018; 51(1): 147-158.

  7. Gimeno-Aranguez M, Colomar-Palmer P, González-mediero I et al. Aspectos clínicos y morfológicos de los linfangiomas infantiles: revisión de 145 casos. An Esp Pediatr. 1996; 45: 25-28.

  8. Rodríguez J, Cáceres F, Vargas P. Manejo del linfangioma con infiltración de OK-432. Cir Pediatr. 2012; 25: 201-204.

  9. De Oliveira-Olímpio H, Bustorff-Silva J, De Oliveira-Filho AG. Cross-sectional study comparing different therapeutic modalities for cystic lymphangiomas in children. Clinics. 2014; 69: 505-508.

  10. Damaskos C, Garmpis N, Manousi M et al. Cystic hygroma of the neck: single center experience and literature review. Eu Re Med Pharmacol Sci. 2017; 21: 4918-4923.

  11. Hesham Y, Hasan A, RIzwan MA. Efficacy of OK-432 therapy for the incisionless treatment of head and neck cystic masses. Sultan Qaboos University Med J. 2018; 18: 88-92.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2020;87